(226 days)
Not Found
No
The summary describes a device family utilizing IPL, IR, and Laser technologies for dermatological treatments. The device description focuses on the hardware platform and embedded software for controlling parameters. There is no mention of AI, ML, image processing, or any data-driven decision-making processes that would indicate the use of AI/ML. The performance studies are based on substantial equivalence to predicate devices, not on the performance of an AI/ML algorithm.
Yes
The device is indicated for various dermatological treatments of medical conditions and for the photocoagulation of soft tissue, which suggests a therapeutic purpose.
No
The device is described as a "Dermatological Treatment Systems" device family, with its intended use explicitly stated for "aesthetic and cosmetic applications and in selective treatments required in the medical specialties of dermatology." It lists various treatments such as hair removal, treatment of vascular lesions, and skin resurfacing. There is no mention of the device being used for diagnosis, only for therapeutic procedures.
No
The device description explicitly states it is a "platform system" designed to support various "treatment technologies hand pieces (i.e. IPL, IR and Laser)" and that the "embedded software is the heart of the control system". This indicates the device includes hardware components (the platform system and hand pieces) in addition to the software.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use/Indications for Use: The intended use and indications clearly describe the device as being used for dermatological treatments performed directly on the human body (hair removal, treatment of lesions, wrinkles, tattoos, etc.). These are all procedures that involve interacting with the patient's skin and soft tissue.
- Device Description: The description confirms that the device delivers energy (IPL, IR, Laser) to the human skin for dermatological treatments.
- Anatomical Site: The specified anatomical sites are human skin and various soft tissues within the body.
In Vitro Diagnostic (IVD) devices are used to examine specimens (like blood, urine, tissue samples) taken from the human body to provide information about a person's health. This device does not perform such analysis on specimens. It directly treats the patient's body.
N/A
Intended Use / Indications for Use
The DTS device family, a modification to the legally cleared device family (K082876), uses IPL, IR, Laser and RF energy sources, is intended for dermatological treatments.
The DTS device family is indicated for dermatological treatments such as, but not limited to:
-
- Hair removal in all skin types to the Fitzpatrick scale. Permanent Hair Reduction.
-
- Treatment of Vascular Lesions
-
- Treatment of Inflammatory Acne (acne vulgaris)
-
- Treatment of Benign Pigmented Epidermal and Cutaneous Lesions including warts, scars and striae.
-
- Treatment of Wrinkles, rhytids and Periorbital Wrinkles
-
- Skin resurfacing (Acne scars)
-
- Treatment of Tattoos
-
- Treatment of Leg and Facial Vein Removal
-
- Treatment of photocoagulation of soft tissue in dermatologic applications
-
- Resurfacing of the skin, and for the treatment of facial wrinkles.
The Dermatological Treatment Systems device family and optional Hand Piece family are intended for use in aesthetic and cosmetic applications and in selective treatments required in the medical specialties of dermatology.
The Dermatological Treatment device family and optional Hand pieces with 415 -1200 nm wavelengths (with and without contact-cooling) are indicated for:
-
- Hair removal and Permanent Hair Reduction in all skin types (I-VI) to the Fitzpatrick scale - Recommended wavelengths in the range of 635-950 nm, 730-950 nm or 580-950 nm
-
- Treatment of Pigmented and Vascular Lesions in all skin types (I-VI) to the Fitzpatrick scale - Recommended wavelength in the range of 535-950 nm
-
- Treatment of Inflammatory Acne (acne vulgaris) in skin types (I-V) to the Fitzpatrick scale - Recommended wavelength in the range of 415-950 nm
-
- Treatment of Benign Pigmented Epidermal and Cutaneous Lesions including warts, scars and striae in all skin types (I-VI) to the Fitzpatrick scale - Recommended wavelength in the range of 580-950 nm
- *Treatment of Benign Pigmented Epidermal, Cutaneous and Vascular Lesions including warts; scars and striae in skin types (I-V) to the Fitzpatrick scale - Recommended wavelength in the range of 535-680 nm & 860-1200nm
The Dermatological Treatment device family and optional Infrared (IR) Hand Pieces with 850 - 1750 nm wavelengths (with contact cooling) is indicated for:
-
- Dermatologic Treatment such as, but not limited to: photocoagulation of soft tissue (Scars, Wrinkles, Rhytids and Periorbital Wrinkles)
The Dermatological Treatment device family and optional Nd: YAG Laser 1064 nm Long Pulse (LP) Hand Pieces is indicated for:
- Dermatologic Treatment such as, but not limited to: photocoagulation of soft tissue (Scars, Wrinkles, Rhytids and Periorbital Wrinkles)
-
- Removal of unwanted hair, for stable long-term, or permanent, hair reduction through selective targeting of melanin in hair follicles.
-
- Removal or lightening of unwanted hair (with and without adjuvant preparation)
-
- Treatment of pseudofolliculitis barbae (PFB)
The Dermatological Treatment device family and optional Nd:YAG Laser 1064 nm Long Pulse (LP) and Q-Switched Hand Pieces is indicated for:
-
- Benign vascular lesions such as, but not limited to treatment of: Port wine stains; Hemangiomas; Warts, Superficial and deep telangiectasias (venulectasias); Reticular veins (0.1-4.0 mm dia.) of the leg; Rosacea; Venus lake; Leg veins; Spider veins; Poikiloderma of Civatte; Angiomas
-
- Benign cutaneous lesions, such as, but not limited to: Warts; Scars; Striae; Psoriasis
-
- Benign pigmented lesions such as, but not limited to: Lentigos (age spots); Solar lentigos (sun spots); Cafe-au-lait macules; Seborrheic; keratoses; Nevi and nevus of Ota, Chloasma; Verrucae; Skin tags; Keratoses; The removal of black, blue or green tattoos (significant reduction in the intensity of black and /or blue/black tattoos); Plaques
-
- Pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment and for patients with lesions that have not responded to other laser treatments.
-
- The non-ablative treatment of facial wrinkles, such as, but not limited to: Periocular wrinkles; Perioral wrinkles
Continued : The Dermatological Treatment device family and optional Nd:YAG Laser 1064 nm Long Pulse (LP) and Q-Switched Hand Pieces is indicated for:
- Laser skin resurfacing procedures for the treatment of: Acne scars; Wrinkles
-
- Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar.
- Indicated for use on all skin types (Fitzpatrick I-VI), including tanned skin.
The Dermatological Treatment device family and optional Nd:YAG Laser 532 mm Frequency Dabbler (FD) Long Pulse (LP) and Q-Switched Hand Pieces is indicated for:
- Tattoo removal: Light blue; Yellow; Red; Green
-
- Vascular lesions: Hemangiomas (Port wine stains/birthmarks, cavernous, cherry, spider); hemangiomas; Angiomas (cherry, spider); Telangiectasia; Spider nevi
-
- Benign pigmented lesions, such as, but not limited to: Cafe-au-lait (macules); Lentigines (senile and solar); Freckles (ephelides); Chloasma; Nevi; Nevus spillus, Nevus of Ota: Becker's Nevi;
-
- Other pigmented cutaneous lesions, such as, but not limited to: Verrucae; Skin tags; Keratoses; Plaques
The Dermatological Treatment device family and optional Er:YAG Laser 2940 nm Long Pulse (LP) Hand Pieces, with standard and scanner accessory tips is indicated for:
Use in soft tissue (skin, cutaneous tissue, subcutaneous tissue, striated and smooth tissue, muscle, cartilage meniscus, mucous membrane, lymph vessels and nodes, organs, and glands) such as, but not limited to:
- Dermatology and plastic Surgery: Skin resurfacing; Treatment of wrinkles; Epidermal nevi; Telangiectasia; Spider veins; Actinic chelitis; Keloids; Verrucae; Skin tags; Anal tags; Keratoses; Scar revision (including acne scars);
Product codes (comma separated list FDA assigned to the subject device)
GEX, NUV, ONG, ONE, ONF, GEI
Device Description
The Dermatologic Treatment Systems (DTS) device family and optional hand pieces, including Intensive Pulse Light (IPL) Infrared light (IR) and Laser light technologies for dermatological treatments by delivery of energy to the human skin. The device family is a modification to the BeaMax/ ForMax family (K082876), pulsed light energy device based on a filtered, Xenon flashlamp.
The DTS device family modification enhances capabilities of the legally cleared Beamax/ Formax device family by adding new hand pieces that are now supporting Laser and IR technologies as well as the IPL technology.
The Basic unit is a platform system, designed to support all treatment technologies hand pieces (i.e. IPL, IR and Laser).
The embedded software is the heart of the control system which provides a control of all of the parameters to the relevant hand piece, where the operator has the access to modify some parameters via the touch screen and every hand piece has its own operating screen.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
human skin, facial, leg, periorbital, periocular
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The DTS device family was compared to the predicate devices in terms of intended use, indications for use, components, principles of operation, technological characteristics and safety features.
Based on the performance results provided (including test results and clinical data) and the analysis of similarities and differences presented above, SharpLight Technologies Ltd. believes that the proposed device family safe & effectiveness is substantially equivalent to the predicate devices without raising new safety and/or effectiveness issues.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K082870, K07256, K05004, K060065
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 878.4810 Laser surgical instrument for use in general and plastic surgery and in dermatology.
(a)
Identification. (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.
(b)
Classification. (1) Class II.(2) Class I for special laser gas mixtures used as a lasing medium for this class of lasers. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 878.9.
0
Image /page/0/Picture/1 description: The image contains a logo with the word "Sharplight" written in a stylized font. Above the word, there is a rectangular shape on the left and some text on the right. In the middle, there is a small square shape.
DEC 2 1 2011
510(k) Summary
This 510(k) summary of safety and effectiveness information is submitted in accordance with the requirements of the Safe Medical Devices Act (SMDA) of 1990. The contents of the 510(k) summary have been provided in conformance with 21 CFR §807.92
Submitter Information
SharpLight Technologies Ltd. 33 Lazarov St. Rishon Le Zion 75658, Israel Tel: (972) 3 9611969, Fax: (972) 3 9528890 Submission contact person: Ilan Sharon P.O.B. 4262, Zichron Yaacov 30900, Israel TEL: 972-52-8704904
Device Classification
| Proprietary Device Name: | Dermatological Treatment Systems device family |
|---|---|
| Common name: | Multi-Application Dermatological Treatment device family |
| Product Code: | Primary GEX, Secondary NUV, ONG, ONE, ONF |
| Classification Name: | Laser Surgical Instrument, for use in General and Plastic Surgery |
| and Dermatology | |
| Classification Regulation: | 21 CFR § 878.4810 |
| Regulatory Class: | II |
Identification of Legally Marketed Predicate Devices
| SharpLight - BEAMAX/FORMAX Pulse Light device family - | K082870 |
|---|---|
| Alma lasers - Harmony XLTM Multi-Application Platform - | K07256- |
| Cutera Optional Pulsed Light Hand Piece Family - | K05004 |
| Palomar LuxIR Fractional Hand piece - | K060065 |
Device Description
The Dermatologic Treatment Systems (DTS) device family and optional hand pieces, including Intensive Pulse Light (IPL) Infrared light (IR) and Laser light technologies for dermatological treatments by delivery of energy to the human skin. The device family is a modification to the BeaMax/ ForMax family (K082876), pulsed light energy device based on a filtered, Xenon flashlamp.
The DTS device family modification enhances capabilities of the legally cleared Beamax/ Formax device family by adding new hand pieces that are now supporting Laser and IR technologies as well as the IPL technology.
The Basic unit is a platform system, designed to support all treatment technologies hand pieces (i.e. IPL, IR and Laser).
The embedded software is the heart of the control system which provides a control of all of the parameters to the relevant hand piece, where the operator has the access to modify some parameters via the touch screen and every hand piece has its own operating screen.
1
Intended Use of Device
The DTS device family, a modification to the legally cleared device family (K082876), uses IPL, IR, Laser and RF energy sources, is intended for dermatological treatments.
The DTS device family is indicated for dermatological treatments such as, but not limited to:
-
- Hair removal in all skin types to the Fitzpatrick scale. Permanent Hair Reduction.
-
- Treatment of Vascular Lesions
-
- Treatment of Inflammatory Acne (acne vulgaris)
-
- Treatment of Benign Pigmented Epidermal and Cutaneous Lesions including warts, scars and striae.
-
- Treatment of Wrinkles, rhytids and Periorbital Wrinkles
-
- Skin resurfacing (Acne scars)
-
- Treatment of Tattoos
-
- Treatment of Leg and Facial Vein Removal
-
- Treatment of photocoagulation of soft tissue in dermatologic applications
-
- Resurfacing of the skin, and for the treatment of facial wrinkles.
Safety & Effectiveness
The DTS device family was compared to the predicate devices in terms of intended use, indications for use, components, principles of operation, technological characteristics and safety features.
Based on the performance results provided (including test results and clinical data) and the analysis of similarities and differences presented above, SharpLight Technologies Ltd. believes that the proposed device family safe & effectiveness is substantially equivalent to the predicate devices without raising new safety and/or effectiveness issues.
Rational for Substantial Equivalency
Similarities:
The intended use and indications of the DTS device familar to the legally cleared predicate devices.
The technology, performance and most of the specifications of the DTS device family are similar to the legally marketed predicate devices
Differences:
The DTS device family wider indications for use enhances their capability to perform dermatological treatments, by using the different technologies (IPL, Laser and IR), while predicate devices are capable of supporting partial treatments only.
Substantial Equivalence Statement
Based on the above, it is SharpLight's opinion that the proposed DTS device family is substantially equivalent in terms design principles, performance features and of safety & effectiveness to the unmodified BeaMax/ ForMax family (K082876) legally cleared device and to the legally cleared predicate devices referred to in chapter 4 of this submission.
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" around the perimeter. Inside the circle is an abstract symbol resembling an eagle or bird in flight, composed of three curved lines.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
DEC 2 1 2011
SharpLight Technologies, Ltd. . % Mr. Ilan Sharon P.O. Box 4262 Zichron Yaacov Israel 30900
Re: K111303
Trade/Device Name: Dermatological Treatment Device Family Regulation Number: 21 CFR 878.4810 Regulation Name: Laser surgical instrument for use in general and plastic surgery and in dermatology Regulatory Class: Class II Product Code: GEX, GEI Dated: December 16, 2011 Received: December 20, 2011
Dear Mr. Sharon:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 - Mr. Ilan Sharon
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
Mark N. Melkerson
Director Division of Surgical, Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
510(k) Number (if known): K111303
Device Name: Dermatological Treatment Systems Device Family
Indications for Use:
The Dermatological Treatment Systems device family and optional Hand Piece family are intended for use in aesthetic and cosmetic applications and in selective treatments required in the medical specialties of dermatology.
The Dermatological Treatment device family and optional Hand pieces with 415 -1200 nm wavelengths (with and without contact-cooling) are indicated for:
-
- Hair removal and Permanent Hair Reduction in all skin types (I-VI) to the Fitzpatrick scale - Recommended wavelengths in the range of 635-950 nm, 730-950 nm or 580-950 nm
-
- Treatment of Pigmented and Vascular Lesions in all skin types (I-VI) to the Fitzpatrick scale - Recommended wavelength in the range of 535-950 nm
-
- Treatment of Inflammatory Acne (acne vulgaris) in skin types (I-V) to the Fitzpatrick scale - Recommended wavelength in the range of 415-950 nm
-
- Treatment of Benign Pigmented Epidermal and Cutaneous Lesions including warts, scars and striae in all skin types (I-VI) to the Fitzpatrick scale - Recommended wavelength in the range of 580-950 nm
- *Treatment of Benign Pigmented Epidermal, Cutaneous and Vascular Lesions including warts; scars and striae in skin types (I-V) to the Fitzpatrick scale - Recommended wavelength in the range of 535-680 nm & 860-1200nm
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Nil Re ach for mxm
(Division Sign-Off) Division of Surgical, Orthopedic, and Restorative Devices
510(k) Number K111303
Page 1 of 5
5
510(k) Number (if known): K111303
Device Name: Dermatological Treatment device family
Indications for Use: Continued from last page.
The Dermatological Treatment device family and optional Infrared (IR) Hand Pieces with 850 - 1750 nm wavelengths (with contact cooling) is indicated for:
-
- Dermatologic Treatment such as, but not limited to: photocoagulation of soft tissue (Scars, Wrinkles, Rhytids and Periorbital Wrinkles)
The Dermatological Treatment device family and optional Nd: YAG Laser 1064 nm Long Pulse (LP) Hand Pieces is indicated for:
-
- Removal of unwanted hair, for stable long-term, or permanent, hair reduction through selective targeting of melanin in hair follicles.
-
- Removal or lightening of unwanted hair (with and without adjuvant preparation)
-
- Treatment of pseudofolliculitis barbae (PFB)
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
- Neil RP agle for nxn
(Division Sign-Off) Division of Surgical, Orthopedic, and Restorative Devices
Page 2 of 5_
510(k) Number.
6
510(k) Number (if known): K111303
Device Name: Dermatological Treatment device family
Indications for Use: Continued from last page.
The Dermatological Treatment device family and optional Nd:YAG Laser 1064 nm Long Pulse (LP) and Q-Switched Hand Pieces is indicated for:
-
- Benign vascular lesions such as, but not limited to treatment of: Port wine stains; Hemangiomas; Warts, Superficial and deep telangiectasias (venulectasias); Reticular veins (0.1-4.0 mm dia.) of the leg; Rosacea; Venus lake; Leg veins; Spider veins; Poikiloderma of Civatte; Angiomas
-
- Benign cutaneous lesions, such as, but not limited to: Warts; Scars; Striae; Psoriasis
-
- Benign pigmented lesions such as, but not limited to: Lentigos (age spots); Solar lentigos (sun spots); Cafe-au-lait macules; Seborrheic; keratoses; Nevi and nevus of Ota, Chloasma; Verrucae; Skin tags; Keratoses; The removal of black, blue or green tattoos (significant reduction in the intensity of black and /or blue/black tattoos); Plaques
-
- Pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment and for patients with lesions that have not responded to other laser treatments.
-
- The non-ablative treatment of facial wrinkles, such as, but not limited to: Periocular wrinkles; Perioral wrinkles
Prescription Use X (Part 21 CFR 801 Subpart D)
Over-The-Counter Use AND/OR (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Neil RP Oden for man
(Division Sign Division of Surgical, Orthopedic, and Restorative Devices
· 510(k) Number.
Page 3 of 5
7
510(k) Number (if known): K111303
Device Name: Dermatological Treatment device family
Indications for Use: Continued from last page.
Continued : The Dermatological Treatment device family and optional Nd:YAG Laser 1064 nm Long Pulse (LP) and Q-Switched Hand Pieces is indicated for:
- Laser skin resurfacing procedures for the treatment of: Acne scars; Wrinkles
-
- Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar.
- Indicated for use on all skin types (Fitzpatrick I-VI), including tanned skin.
The Dermatological Treatment device family and optional Nd:YAG Laser 532 mm Frequency Dabbler (FD) Long Pulse (LP) and Q-Switched Hand Pieces is indicated for:
- Tattoo removal: Light blue; Yellow; Red; Green
-
- Vascular lesions: Hemangiomas (Port wine stains/birthmarks, cavernous, cherry, spider); hemangiomas; Angiomas (cherry, spider); Telangiectasia; Spider nevi
-
- Benign pigmented lesions, such as, but not limited to: Cafe-au-lait (macules); Lentigines (senile and solar); Freckles (ephelides); Chloasma; Nevi; Nevus spillus, Nevus of Ota: Becker's Nevi;
-
- Other pigmented cutaneous lesions, such as, but not limited to: Verrucae; Skin tags; Keratoses; Plaques
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Neil RP Dade formxn
(Division Sign-Off) Division of Surgical, Orthopedic, and Restorative Devices
KIII 303 510(k) Number_
Page 4_ of 5_
8
510(k) Number (if known): K111303
Device Name: Dermatological Treatment device family
Indications for Use: Continued from last page.
The Dermatological Treatment device family and optional Er:YAG Laser 2940 nm Long Pulse (LP) Hand Pieces, with standard and scanner accessory tips is indicated for:
Use in soft tissue (skin, cutaneous tissue, subcutaneous tissue, striated and smooth tissue, muscle, cartilage meniscus, mucous membrane, lymph vessels and nodes, organs, and glands) such as, but not limited to:
- Dermatology and plastic Surgery: Skin resurfacing; Treatment of wrinkles; Epidermal nevi; Telangiectasia; Spider veins; Actinic chelitis; Keloids; Verrucae; Skin tags; Anal tags; Keratoses; Scar revision (including acne scars);
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
Prescription Use X (Part 21 CFR 801 Subpart D)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Net RPD sale for mxm
(Division Sign bm)
Division Sign Division of Surgical, Orthopedic, and Restorative Devices
510(k) Number K111303
Page 5_ of 5_